Patents
Patents for C07K 1 - General processes for the preparation of peptides (51,718)
06/2007
06/21/2007US20070142625 Virus filtration of liquid Factor VII compositions
06/21/2007US20070141724 Solid phase immobilized trifunctional linker
06/21/2007US20070138014 Buffers for electrophoresis and use thereof
06/21/2007US20070138013 DNA separation device, DNA separation method, and ligand DNA
06/21/2007DE10229376B4 Vorrichtung zur hochparallelen mikrochemischen Synthese Apparatus for highly parallel micro-chemical synthesis
06/21/2007DE102005060392A1 Separating proteins from liquid media, useful e.g. for isolation of proteins from bioreactors or body fluids, using specific clay material that does not swell much in water
06/21/2007CA2628798A1 Process for the purification of macrolide antibiotics
06/21/2007CA2571097A1 Comparative two-and three-dimensional gel electrophoresis systems
06/20/2007EP1798237A1 Process for the purification of macrolide antibiotics
06/20/2007EP1797117A2 Cloning and expression of recombinant adhesive protein mefp-1 of the blue mussel, mytilus edulis
06/20/2007EP1797114A2 Cupredoxin derived transport agents and methods of use thereof
06/20/2007EP1797112A2 Inhibitors of hepatitits c virus
06/20/2007EP1797109A2 Mixtures of polypeptides, compositions containing and processes for preparing same, and uses thereof
06/20/2007EP1796712A2 Methods and compositions for treating hypercholesterolemia
06/20/2007EP1796694A2 Methods to enhance hemodynamic stability using oxygen carrying compositions
06/20/2007EP1616003A4 Water-soluble thioester and selenoester compounds and methods for making and using the same
06/20/2007EP1565744A4 Microarrays of cellulose binding chimeric proteins and methods of use thereof
06/20/2007EP1436331B1 Process for the production of egg yolk antibodies against organochlorine pesticides
06/20/2007EP1124946B1 Glycosylated proteins having reduced allergenicity
06/20/2007CN1984924A Methods for increasing conjugation of protein and polyethylene glycol (PEG)
06/20/2007CN1982458A Amphioxus galactose lectin AmphiGAL13-gene and its use
06/20/2007CN1982335A Production of trichosanthin by one-step method
06/20/2007CN1982330A Methods for preparing purified lipopeptides
06/20/2007CN1322006C Method for extracting and separating protein from roots of kudzu vine
06/20/2007CN1322004C Micro-fluidic chip for isolation analysis of protein and isolation analysis method
06/20/2007CN1322003C Methods of producing target molecule in transgenic animal and purification of target molecule
06/19/2007US7232924 Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
06/19/2007US7232894 Method for the production of recombinant peptides with a low amount of trisulfides
06/19/2007US7232893 Producing conditioned media from an immortalized hepatocyte, applying the conditioned media to at least one column, and collecting fractions containing a stellate cell death factor wherein the stellate cell death factor is capable of activating caspase 7 in a liver stellate cell
06/19/2007US7232882 Polypeptides having specific amino acid sequence lacking its associated signal peptide; a chimeric polypeptide fused to a heterologous polypeptide which is an epitope tag or an Fc region of an immunoglobulin
06/19/2007US7232690 Adding a target to mixture and forming a complex of target and at least one active chemical substance of the mixture,separating the complex from the inactive chemical substances of the mixture, andeitherliberating and isolating and/or identifying at least one active chemical substance
06/19/2007US7232672 P450 enzymes, nucleic acids encoding them and methods of making and using them
06/19/2007US7232670 Therapy lysosomal storage disorder other than Fabry Disease caused by a deficiency of a specific protein comprising: producing protein or an active fragment thereof in an insect cell culture, administering the protein
06/19/2007US7232569 Type III secretion pathway in aeromonas salmonicida, and uses therefor
06/19/2007US7232562 E38N interferon gamma polypeptide variants
06/19/2007CA2195127C Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation
06/19/2007CA2189690C Novel active peptide and its preparation
06/14/2007WO2007067539A2 High density metal ion affinity compositions and methods for making and using the same
06/14/2007WO2007066923A1 A prepartion method for a protein with new function through simultaneous incorporation of functional elements
06/14/2007WO2007065973A1 Labeling reactants suitable for solid-phase synthesis
06/14/2007WO2007065918A2 Method for purifying fsh or a fsh mutant
06/14/2007WO2007065812A1 Process for the preparation of ferri-succinylcasein
06/14/2007US20070135698 Subcutaneous or transcutaneous monitoring of blood glucose levels in a diabetic patient; biocompatible polymer composition that is impermeable to immunoglobulins and permeable to oxygen, glucose and lactate; a second layer of porous functionalized polysiloxane; durabiliity
06/14/2007US20070135514 Methods for the identification of agents for the treatment of seizures, neurological diseases, endocrinopathies and hormonal diseases
06/14/2007US20070135349 Method for increasing the serum half-life of a biologically active molecule
06/14/2007US20070134812 Controlled electrophoresis method
06/14/2007US20070134757 Method for cleaving proteins
06/14/2007US20070134737 Fluorophore compounds and their use in biological systems
06/14/2007US20070134653 drug screening using virion infectivity factor (VIF) activity as diagnostic tool in screening viricidal activity of compounds; for treating viral diseases
06/14/2007US20070134648 Affinity-based enrichment of phosphorylated peptides and/or proteins
06/14/2007US20070131552 Biomolecule detection device, mobile phone for biomolecule detection, and biomolecule detection method
06/14/2007DE102005059379A1 Polymers and dendrimers with bisphosphonate groups used e.g. in purifying natural or recombinant basic and arginine-tagged proteins are obtained by polymerization of methacrylate-based neutral phosphonic acid dimethyl esters
06/14/2007CA2826960A1 Targeting vector-phospholipid conjugates
06/14/2007CA2632714A1 Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins
06/14/2007CA2628614A1 Process for the preparation of ferri-succinylcasein
06/14/2007CA2625978A1 Method for purifying fsh or a fsh mutant
06/13/2007EP1795205A2 Method for accessing microbial diversity
06/13/2007EP1794318A2 Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof
06/13/2007EP1794181A2 Methods and materials for optimization of electronic transportation and hybridization reactions
06/13/2007EP1794180A1 Peptide cyclisation
06/13/2007EP1794179A1 Ring-closing metathesis process in supercritical fluid
06/13/2007EP1794178A1 Process for preparing macrocyclic hcv protease inhibitors
06/13/2007EP1793847A2 Use of microproteins as tryptase inhibitors
06/13/2007EP1746902A4 Multi-lectin affinity chromatography and uses thereof
06/13/2007EP1583816A4 Protein arrays
06/13/2007EP1275004B1 Mass labels
06/13/2007EP1244690B1 Method for preparing a polypeptide soluble in an aqueous solvent in the absence of detergent
06/13/2007EP1176870B1 Tgf-alpha polypeptides, functional fragments and methods of use therefor
06/13/2007EP0914431B1 Truncated soluble tumor necrosis factor type-i receptors
06/13/2007EP0876401B1 Methods for producing op-1 morphogen analogs
06/13/2007CN2910926Y Electric elution and recovery of protein tank
06/13/2007CN1980698A Modulation of immunoglobulin production and atopic disorders
06/13/2007CN1980692A Polypeptides for inducing a protective immune response against staphylococcus aureus
06/13/2007CN1978464A Ray angio-genesis inhibiting factor I separating, purifying and its N end aminoacid sequence
06/13/2007CN1978462A Imidazoline modified amino acid, and its synthesizing method and use for polypeptide marking
06/13/2007CN1978461A End miercapto modified peptide nucleic acid oligomer compound synthesizing method
06/13/2007CN1978460A PNA oligomer NH2TTTOH solid-phase synthesis method
06/13/2007CN1978454A Modular peptide-based reagent
06/13/2007CN1321133C Human blood high density lipoprotein and its preparation method and use
06/13/2007CN1321132C Batyl active peptide, preparation and therepic use thereof
06/13/2007CN1320939C Method for enhancing dynamic absorption volume of ion exchange absorbent of transverse electric field
06/12/2007US7231328 Apparatus and method for designing proteins and protein libraries
06/12/2007US7230095 Such as thrombin binding aptamer attached by terminal phosphate to amino sepharose via carbodiimide mediated coupling
06/12/2007US7230088 Compounds for dual photodiagnosis and therapy
06/12/2007US7230080 new fluorescent and/or colored proteins; wider array of colors and biochemical features compared to existing wild-type green fluorescent protein
06/12/2007US7230079 purified anti-allergic royal jelly protein; foods, cosmetics, pharmaceuticals
06/12/2007US7230075 Coccidiosis poultry vaccine
06/12/2007US7230072 Site-selective acyl transfer
06/12/2007US7229960 Administering a non-phosphorylated tripeptides
06/12/2007US7229789 Methods and compositions for extracting proteins from cells
06/12/2007US7229788 Mutating one or more of the amino acid residues of the amino acid sequence, in the tropoelastin, so that susceptibility of the tropoelastin to cleavage by thrombin, kallikrein or serum is reduced
06/12/2007US7229777 Providing a library of peptides comprising a trpzip scaffold, contacting the library with the bioactive target molecule; selecting at least one peptide capable of forming a noncovalent complex with the bioactive target molecule from the library; isolating peptide
06/12/2007US7229771 Polyethylene glycol-derivatized biomolecules and their use in heterogeneous detection methods
06/12/2007US7229755 Isolating a biological specimen from a human; testing the specimen for an alteration in a human MSH2 nucleotide sequence or its expression product; comparing the results obtained with the results obtained from a wild type control
06/12/2007US7229620 for radiolabeling proteins, peptides and ligands with therapeutic radioisotopes such that these radiolabeled agents may be administered directly to patients without the need for additional purification; for the treatment of cancer
06/12/2007US7229554 at 66 to 90 degrees C. of a fermentation-derived product, particularly microbially derived protein; especially cross flow microfiltration using backshock with a vibrating membrane in the absence of activated carbon
06/12/2007CA2133436C Methods for producing eg iii cellulase, xylanase or a mixture thereof using polyethylene glycol
06/07/2007WO2007063907A1 Sugar chain adduct of peptide and pharmaceutical comprising the same as active ingredient
06/07/2007WO2007063299A1 Method for the purification of alpha-1-antitrypsin
06/07/2007WO2007062800A1 Methods and apparatus for measuring the concentration of a substance in a solution